Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Clover Health Investments Corp (CLOV)

Clover Health Investments Corp (CLOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,012,607
  • Shares Outstanding, K 524,667
  • Annual Sales, $ 1,924 M
  • Annual Income, $ -85,550 K
  • EBIT $ -84 M
  • EBITDA $ -84 M
  • 60-Month Beta 2.24
  • Price/Sales 0.52
  • Price/Cash Flow N/A
  • Price/Book 3.21

Options Overview Details

View History
  • Implied Volatility 84.18% (-1.47%)
  • Historical Volatility 46.54%
  • IV Percentile 51%
  • IV Rank 10.27%
  • IV High 394.35% on 09/10/25
  • IV Low 48.69% on 06/03/25
  • Expected Move (DTE 3) 0.0850 (4.19%)
  • Put/Call Vol Ratio 0.62
  • Today's Volume 19,388
  • Volume Avg (30-Day) 13,384
  • Put/Call OI Ratio 0.22
  • Today's Open Interest 294,236
  • Open Int (30-Day) 284,675
  • Expected Range 1.9450 to 2.1150

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $0.03
  • Number of Estimates 1
  • High Estimate $0.03
  • Low Estimate $0.03
  • Prior Year $0.00
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5800 +28.48%
on 04/01/26
2.0400 -0.49%
on 04/13/26
+0.0500 (+2.53%)
since 03/13/26
3-Month
1.5800 +28.48%
on 04/01/26
2.8800 -29.51%
on 01/14/26
-0.5100 (-20.08%)
since 01/13/26
52-Week
1.5800 +28.48%
on 04/01/26
3.9200 -48.21%
on 10/24/25
-1.6500 (-44.84%)
since 04/11/25

Most Recent Stories

More News
Clover Health (NASDAQ:CLOV): Strongest Q4 Results from the Health Insurance Providers Group

Clover Health (NASDAQ:CLOV): Strongest Q4 Results from the Health Insurance Providers Group

CLOV : 2.0300 (+5.18%)
Clover Health to Report First Quarter 2026 Financial Results on May 6, 2026

WILMINGTON, Del., April 08, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its...

CLOV : 2.0300 (+5.18%)
Alignment Healthcare, Centene, CVS Health, Elevance Health, and Clover Health Stocks Trade Up, What You Need To Know

Alignment Healthcare, Centene, CVS Health, Elevance Health, and Clover Health Stocks Trade Up, What You Need To Know

CVS : 78.09 (-1.56%)
ALHC : 20.98 (+2.34%)
CNC : 37.47 (+0.46%)
ELV : 316.07 (+1.46%)
CLOV : 2.0300 (+5.18%)
Clover Health Empowers Members to Take Charge of Their Health Data Through HealthEx Partnership

WILMINGTON, Del., April 07, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed...

CLOV : 2.0300 (+5.18%)
Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026

WILMINGTON, Del., April 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”), a physician enablement company committed to bringing access to...

CLOV : 2.0300 (+5.18%)
3 Reasons to Avoid CLOV and 1 Stock to Buy Instead

3 Reasons to Avoid CLOV and 1 Stock to Buy Instead

CLOV : 2.0300 (+5.18%)
Primary Care Physician Use of Counterpart Assistant Associated with 18%–22% Fewer Flu-Related Acute Care Events Among COPD and CHF Patients

SAN FRANCISCO, March 19, 2026 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health”...

CLOV : 2.0300 (+5.18%)
1 Unprofitable Stock for Long-Term Investors and 2 We Ignore

1 Unprofitable Stock for Long-Term Investors and 2 We Ignore

RUN : 12.76 (-3.92%)
WBTN : 11.56 (+3.96%)
CLOV : 2.0300 (+5.18%)
UPDATED – Moving from Pledge to Production, Clover Health is Now Live on Kno2, Participating in Recently Announced Federal Interoperability Initiatives

NOTICE: This is an updated version of a press release originally issued March 4, 2026 by Clover Health Investments, Corp. (Nasdaq: CLOV). Language has been updated to further refine the description of...

CLOV : 2.0300 (+5.18%)
1 Cash-Heavy Stock with Impressive Fundamentals and 2 We Ignore

1 Cash-Heavy Stock with Impressive Fundamentals and 2 We Ignore

NU : 14.95 (-0.07%)
PRLB : 62.82 (+2.31%)
CLOV : 2.0300 (+5.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia...

See More

Key Turning Points

3rd Resistance Point 2.2500
2nd Resistance Point 2.1500
1st Resistance Point 2.0900
Last Price 2.0300
1st Support Level 1.9200
2nd Support Level 1.8200
3rd Support Level 1.7600

See More

52-Week High 3.9200
Fibonacci 61.8% 3.0300
Fibonacci 50% 2.7500
Fibonacci 38.2% 2.4700
Last Price 2.0300
52-Week Low 1.5800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.